MicroRNAs/LncRNAs Modulate MDSCs in Tumor Microenvironment

Xiaocui Liu1, Shang Zhao2, Hongshu Sui1

  • 1Department of Histology and Embryology, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China.

Frontiers in Oncology
|April 1, 2022
PubMed

Insights

Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), regulate myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment (TME). Understanding these interactions offers new avenues for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Myeloid-derived suppressor cells (MDSCs) are crucial immunosuppressive cells in the tumor microenvironment (TME), driving cancer progression.
  • Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are key regulators of gene expression.
  • Emerging evidence highlights the role of miRNAs and lncRNAs in modulating MDSCs within the TME.

Purpose of the Study:

  • To summarize the regulatory roles of miRNAs and lncRNAs in the differentiation, expansion, and immunosuppressive functions of tumor-associated MDSCs.
  • To focus on the mechanisms by which exosomal miRNAs and lncRNAs influence tumor MDSCs.
  • To discuss the intricate interactions between miRNAs and lncRNAs in modulating tumor MDSCs.

Main Methods:

  • Literature review and synthesis of existing research on ncRNAs and MDSCs.
  • Analysis of regulatory mechanisms of miRNAs and lncRNAs in MDSC biology.
  • Exploration of exosomal transfer and intercellular communication involving ncRNAs and MDSCs.

Main Results:

  • MiRNAs and lncRNAs significantly impact MDSC differentiation, expansion, and immunosuppressive activity in the TME.
  • Exosomal miRNAs and lncRNAs act as critical mediators in intercellular communication, influencing tumor MDSC behavior.
  • The interplay between different types of ncRNAs collectively shapes the function of tumor MDSCs.

Conclusions:

  • MiRNAs and lncRNAs are pivotal in regulating tumor MDSCs and represent promising targets for cancer immunotherapy.
  • Targeting exosomal ncRNAs offers a potential strategy to disrupt MDSC-mediated immunosuppression.
  • Further investigation into the complex interactions of ncRNAs is essential for developing novel cancer therapeutics.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K